{"id":"W3087889571","doi":"10.1016/j.molmet.2020.101090","title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","year":2020,"lang":"en","type":"review","venue":"Molecular Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research; Novo Nordisk Fonden","keywords":"Amylin; Medicine; Exenatide; Semaglutide; Liraglutide; Agonist; Type 2 diabetes; Glycemic; Glucagon-like peptide 1 receptor; Weight loss; Steatohepatitis; Bioinformatics; Diabetes mellitus; Pharmacology; Disease; Internal medicine; Endocrinology; Receptor; Obesity; Biology; Fatty liver; Islet","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002641556,0.001154943,0.004264623,0.0003955945,0.0001624372,0.0001456767,0.0003966505,0.0002172842,0.0001780714],"category_scores_gemma":[0.0002699325,0.0009285127,0.00274764,0.0005614823,0.00008783666,0.00009465887,0.0001764643,0.0003532865,0.0006045348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001210824,"about_ca_system_score_gemma":0.0004956054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001013613,"about_ca_topic_score_gemma":5.116585e-7,"domain_scores_codex":[0.9961393,0.0002212659,0.000957211,0.001243494,0.0006109655,0.0008277405],"domain_scores_gemma":[0.9972989,0.0001041921,0.0005098364,0.00107718,0.0001204094,0.0008894696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000684699,0.0002941748,0.0000033349,0.01390576,0.003917535,0.0002875295,0.0000472152,3.716679e-7,0.00003799281,0.003873011,0.008730744,0.9688339],"study_design_scores_gemma":[0.00177572,0.00008060293,0.0000153448,0.002825055,0.03207603,0.00000656008,0.000009787384,0.00001095957,0.0001098843,0.00005787637,0.9623237,0.0007085357],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002618854,0.9894134,0.0005903475,0.0003393177,0.0007943217,0.005559637,0.0004848622,0.000277052,0.00251484],"genre_scores_gemma":[0.00001350565,0.979032,0.005192779,0.001031663,0.0008567271,0.00276672,0.004441586,0.0003584908,0.006306523],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9681253,"threshold_uncertainty_score":0.9993166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02732589598191354,"score_gpt":0.3265732227397154,"score_spread":0.2992473267578019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}